Aastrom Biosciences Income Statement
View: Annual | Quarterly
| Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|
|---|---|---|---|---|---|
| Revenue | 0.2 | 0.1 | 0.1 | 0.2 | 0.3 |
| Cost of Goods Sold | 0.0 | 0.0 | -- | 0.0 | 0.0 |
| Gross Profit | 0.2 | -- | -- | 0.1 | 0.2 |
| Gross Profit Margin | 85.0% | 0.0% | 0.0% | 93.8% | 96.2% |
| SG&A Expense | 5.3 | 5.6 | 5.4 | 5.3 | 5.2 |
| Depreciation & Amortization | 0.1 | 0.0 | 0.1 | 0.1 | (0.1) |
| Operating Income | (5.3) | (5.5) | (5.4) | (5.2) | (4.9) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 |
| Nonoperating Expenses | 0.0 | 0.0 | 0.0 | -- | -- |
| Income Before Taxes | (5.1) | (5.2) | (5.1) | (4.8) | (4.5) |
| Income Taxes | -- | -- | -- | -- | -- |
| Net Income After Taxes | (5.1) | (5.2) | (5.1) | (4.8) | (4.5) |
| Continuing Operations | (5.1) | (5.2) | (5.1) | (4.8) | (4.5) |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (5.1) | (5.2) | (5.1) | (4.8) | (4.5) |
| Total Net Income | (5.1) | (5.2) | (5.1) | (4.8) | (4.5) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.04) | (0.04) | (0.04) | (0.04) | (0.04) |
| Dividends per Share | -- | -- | -- | -- | -- |






